Two Sigma Investments’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.2K Buy
+10,366
New +$21.3K ﹤0.01% 4800
2025
Q3
– Sell
-35,591
Closed -$82.2K – 3784
2025
Q2
$82.2K Buy
35,591
+5,028
+16% +$36.9K ﹤0.01% 3016
2025
Q1
$239K Sell
30,563
-35,821
-54% -$284K ﹤0.01% 2800
2024
Q4
$310K Buy
66,384
+54,200
+445% +$283K ﹤0.01% 2722
2024
Q3
$65.7K Buy
+12,184
New +$86.6K ﹤0.01% 2950

Other funds holding INMB

Two Sigma Investments's INMB Position: Q3 2026 in Review

Two Sigma Investments opened a new position in INmune Bio (INMB) in Q3 2026: 10,366 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #4800 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in INMB as recently as Q2 2025.

Two Sigma Investments first reported a position in INMB in Q3 2024 and has held it in 5 quarters since. The position peaked at $310K in Q4 2024. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Two Sigma Investments held 10,366 shares of INmune Bio worth $20.2K as of Q3 2026.
  • INmune Bio was a new Two Sigma Investments position in Q3 2026.
  • INmune Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4800 holding.
  • Two Sigma Investments first reported a position in INmune Bio in Q3 2024 and has held it in 5 quarters since.
  • Two Sigma Investments's INmune Bio position peaked at $310K in Q4 2024.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.